Audentes Therapeutics, Inc.
NASDAQ: BOLD
$59.97
+$0.00 (+0.0%)
Closing price January 15, 2020
Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade Desk and Yext.
10 months ago
Last Updated: 8 months ago
Audentes Therapeutics shares more than doubled on Tuesday after the firm announced that it would be acquired by Astellas. Although Audentes has only been public for just over three years, this...
10 months ago
Last Updated: 8 months ago
Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku, Tesla, Uber Technologies and...
10 months ago
Last Updated: 8 months ago
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
1 year ago
Last Updated: 8 months ago